DAVID CHAFFEE: Open Payments
NPI 1063930915 · OCEANSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,035 in 41 payments from 17 companies in 2025. Trend: 2023 $21 · 2024 $124 · 2025 $1,035
Food & beverage: $956Education: $80
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 10 | $255 |
| Actelion Pharmaceuticals US, Inc. | 3 | $147 |
| Novartis Pharmaceuticals Corporation | 6 | $122 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $73 |
| Boston Scientific Corporation | 3 | $65 |
| Merck Sharp & Dohme LLC | 2 | $64 |
| PFIZER INC. | 2 | $56 |
| Amgen Inc. | 2 | $44 |
| Lilly USA, LLC | 2 | $41 |
| Novo Nordisk Inc | 1 | $27 |
Products named: LINQ II, LEQVIO, OPSUMIT, Kerendia, WATCHMAN FLX, VERQUVO, ELIQUIS, REPATHA.
Industry payments across CA — which companies pay providers there.
